HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Debigaré, R. Articles by Price, S. R. Search for Related Content PubMed PubMed Citation Articles by Debigaré, R. Articles by Price, S. R.

INVITED REVIEW

Proteolysis, the ubiquitin-proteasome system, and renal diseases

Renal Division, Emory University, Atlanta, Georgia 30322

Protein degradation is a critical process for the growth and function of cells. Proteolysis eliminates abnormal proteins, controls many cellular regulatory processes, and supplies amino acids for cellular remodeling. When substrates of proteolytic pathways are poorly recognized or there is mistiming of proteolysis, profound changes in cell function can occur. Based on these potential problems, it is not surprising that alterations in proteolytic enzymes/cofactors or in the structure of protein substrates that render them more or less susceptible to degradation are responsible for disorders associated with kidney cell malfunctions. Multiple pathways exist for protein degradation. The best-described proteolytic system is the ubiquitin-proteasome pathway, which requires ATP and degrades the bulk of cellular and some membrane proteins. This review will survey examples of renal abnormalities that are associated with defective protein degradation involving the ubiquitin-proteasome pathway. Loss of muscle mass associated with chronic renal failure, von Hippel-Lindau disease, Liddle syndrome, and ischemic acute renal failure will be discussed. These examples are indicative of the diverse roles of the ubiquitin-proteasome system in renal-associated pathological conditions.

protein degradation; von Hippel-Lindau disease; Liddle syndrome; ischemic acute renal failure; muscle wasting

This article has been cited by other articles:

				R. Tan, W. He, X. Lin, L. P. Kiss, and Y. Liu Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1076 - F1083. [Abstract] [Full Text] [PDF]

				Y. Kamata, Y. Itoh, A. Kajiya, S. Karasawa, C. Sakatani, S. Takekoshi, R. Y. Osamura, and A. Takeda Quantification of Neutral Cysteine Protease Bleomycin Hydrolase and its Localization in Rat Tissues J. Biochem., January 1, 2007; 141(1): 69 - 76. [Abstract] [Full Text] [PDF]

				R. Tan, J. Zhang, X. Tan, X. Zhang, J. Yang, and Y. Liu Downregulation of SnoN Expression in Obstructive Nephropathy Is Mediated by an Enhanced Ubiquitin-Dependent Degradation J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2781 - 2791. [Abstract] [Full Text] [PDF]

				F. Diomedi-Camassei, L. Rava, E. Lerut, F. Callea, and B. Van Damme Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2714 - 2719. [Abstract] [Full Text] [PDF]

				A. R. Chade, J. Herrmann, X. Zhu, J. D. Krier, A. Lerman, and L. O. Lerman Effects of Proteasome Inhibition on the Kidney in Experimental Hypercholesterolemia J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1005 - 1012. [Abstract] [Full Text] [PDF]